Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation

doi:10.3748/wjg.v22.i25.5790

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8064)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

745

WORD

318

HTML

4038

Figures (1-3)

349

Tables (1-5)

279

Sum=5729

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1081

Download

1254

Sum=2335

Jul 7, 2016 (publication date) through Mar 31, 2025

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 7, 2016; 22(25): 5790-5799
Published online Jul 7, 2016. doi: 10.3748/wjg.v22.i25.5790

Table 1 Clinicopathological characteristics of patients with hepatocellular carcinoma recurrence after living donor liver transplantation

Factors	Data, n (%)
Recipient age¹	52.0 ± 8.1
Recipient sex, male	46 (85.2)
Etiology
Hepatitis B	46 (85.2)
Hepatitis C	2 (3.7)
Alcohol	5 (9.3)
Other	1 (1.9)
MELD score¹	11.7 ± 8.5
GRWR¹	1.28 ± 0.24
Pre-transplant locoregional treatment	48 (88.9)
Tumor marker at transplantation
AFP¹	717.3 ± 1748.1 (median: 43.3)
HCC characteristics at pathology
Number¹	2.4 ± 1.9 (median: 2.0)
Maximal tumor size (cm)¹	4.85 ± 4.07 (median: 3.8)
Microvascular invasion	30 (60.0)
E-S grade III-IV	25 (52.1)
Beyond Milan criteria	38 (70.4)
Patterns of HCC recurrence
Time between LDLT and recurrence (mo)¹	15.3 ± 23.9 (median: 6.5, range: 1-150)
Single vs multiple	14 (25.9) vs 40 (74.1)
Intrahepatic vs extrahepatic vs both	12 (22.2) vs 37 (68.5) vs 5 (9.3)
Recurrence organ
Lung	24 (44.4)
Liver	17 (31.3)
Bone	10 (18.5)

¹Values are shown as mean ± SD except where stated otherwise. MELD: Model for end-stage liver disease; GRWR: Graft-to-recipient body weight ratio; AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma; E-S grade: Edmondson-Steiner grade; LDLT: Living donor liver transplantation.

Citation: Na GH, Hong TH, You YK, Kim DG. Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation. World J Gastroenterol 2016; 22(25): 5790-5799
URL: https://www.wjgnet.com/1007-9327/full/v22/i25/5790.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i25.5790